FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981975662> ?p ?o ?g. }

• W1981975662 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCBackground: The immunoproteasome is an alternative form of the constitutive proteasome and it has been increasingly shown to play an important role in a number of diseases including cancer and inflammatory diseases. We have previously developed ‘UK-101’, a small molecule that selectively inhibits the immunoproteasome catalytic subunit LMP2. In our present study, we investigated the frequency of LMP2 expression in primary colon cancers and the impact of targeted inhibition of LMP2 on colon cancer cell survival and apoptosis using UK-101.Methods: The levels of LMP2 expression were assessed in colon cancers and adjacent nonmalignant colonic tissues from the matching donors via immunoblotting and immunohistochemical (IHC) analyses. The frequency of LMP2 expression was further determined by performing IHC staining of LMP2 on a tumor tissue microarray (TMA) containing 153 colorectal adenocarcinomas. Using colon cancer cell lines expressing LMP2 (SW480 and DLD-1), we have investigated the effect of UK-101 on tumor cell survival and apoptosis using the MTS and TUNEL assays. To probe the molecular mechanisms of UK-101-induced cell death, we have compared the effects of UK-101 on a number of apoptosis-related proteins and mediators in apoptotic pathways with those of the broadly acting proteasome inhibitors (bortezomib and epoxomicin).Results: Our immunoblotting and IHC analyses indicated that the LMP2 levels were substantially upregulated in colon cancers compared to the adjacent nonmalignant colonic tissues from the matching donors. The IHC staining on TMA also demonstrated positive immunostaining for LMP2 in approximately 70% of colon cancer specimens evaluated (n=107 out of 153). A number of colon cancer cell lines were found to express LMP2 at differing levels. Using DLD-1 and SW480 cells expressing LMP2 at moderate to high levels, we observed that UK-101 covalently modifies LMP2, but not other catalytic subunits. The UK-101 treatment also induced cell death, measured by the MTS assay and TUNEL staining. Consistent with apoptotic cell death and proteasomal inhibition, UK-101 treated cells showed the cleavage of PARP and caspase-3 and accumulation of polyubiquitinated proteins. Interestingly, the UK-101 treatment did not show any inhibitory effect on the NF-kB pathway, which was observed with bortezomib and epoxomicin.Conclusion: Our results show that the targeted inhibition of LMP2 using UK-101 induces apoptotic cell death in colon cancer. UK-101 does not show any inhibitory effect on the NF-kB pathway in colon cancer cells, suggesting that UK-101 induces colon cancer cell apoptosis via mechanisms different from bortezomib and epoxomicin. Taken together, these results suggest that LMP2 may be a potential therapeutic target in treating colon cancer. Further studies are ongoing to investigate the signaling pathways related to UK-101 induced cell death in colon cancer.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2624." @default.
• W1981975662 created "2016-06-24" @default.
• W1981975662 creator A5018451088 @default.
• W1981975662 creator A5037449477 @default.
• W1981975662 creator A5056530476 @default.
• W1981975662 creator A5059978197 @default.
• W1981975662 creator A5064345133 @default.
• W1981975662 creator A5072803805 @default.
• W1981975662 date "2010-04-15" @default.
• W1981975662 modified "2023-09-26" @default.
• W1981975662 title "Abstract 2624: Targeted inhibition of the immunoproteasome subunit LMP2 using UK-101 induces apoptotic cell death in colorectal cancer" @default.
• W1981975662 doi "https://doi.org/10.1158/1538-7445.am10-2624" @default.
• W1981975662 hasPublicationYear "2010" @default.
• W1981975662 type Work @default.
• W1981975662 sameAs 1981975662 @default.
• W1981975662 citedByCount "0" @default.
• W1981975662 crossrefType "proceedings-article" @default.
• W1981975662 hasAuthorship W1981975662A5018451088 @default.
• W1981975662 hasAuthorship W1981975662A5037449477 @default.
• W1981975662 hasAuthorship W1981975662A5056530476 @default.
• W1981975662 hasAuthorship W1981975662A5059978197 @default.
• W1981975662 hasAuthorship W1981975662A5064345133 @default.
• W1981975662 hasAuthorship W1981975662A5072803805 @default.
• W1981975662 hasConcept C121608353 @default.
• W1981975662 hasConcept C126322002 @default.
• W1981975662 hasConcept C142724271 @default.
• W1981975662 hasConcept C190283241 @default.
• W1981975662 hasConcept C193270364 @default.
• W1981975662 hasConcept C204232928 @default.
• W1981975662 hasConcept C27740335 @default.
• W1981975662 hasConcept C2778367456 @default.
• W1981975662 hasConcept C31573885 @default.
• W1981975662 hasConcept C4224716 @default.
• W1981975662 hasConcept C502942594 @default.
• W1981975662 hasConcept C526805850 @default.
• W1981975662 hasConcept C55493867 @default.
• W1981975662 hasConcept C71924100 @default.
• W1981975662 hasConcept C86803240 @default.
• W1981975662 hasConcept C95444343 @default.
• W1981975662 hasConceptScore W1981975662C121608353 @default.
• W1981975662 hasConceptScore W1981975662C126322002 @default.
• W1981975662 hasConceptScore W1981975662C142724271 @default.
• W1981975662 hasConceptScore W1981975662C190283241 @default.
• W1981975662 hasConceptScore W1981975662C193270364 @default.
• W1981975662 hasConceptScore W1981975662C204232928 @default.
• W1981975662 hasConceptScore W1981975662C27740335 @default.
• W1981975662 hasConceptScore W1981975662C2778367456 @default.
• W1981975662 hasConceptScore W1981975662C31573885 @default.
• W1981975662 hasConceptScore W1981975662C4224716 @default.
• W1981975662 hasConceptScore W1981975662C502942594 @default.
• W1981975662 hasConceptScore W1981975662C526805850 @default.
• W1981975662 hasConceptScore W1981975662C55493867 @default.
• W1981975662 hasConceptScore W1981975662C71924100 @default.
• W1981975662 hasConceptScore W1981975662C86803240 @default.
• W1981975662 hasConceptScore W1981975662C95444343 @default.
• W1981975662 hasLocation W19819756621 @default.
• W1981975662 hasOpenAccess W1981975662 @default.
• W1981975662 hasPrimaryLocation W19819756621 @default.
• W1981975662 hasRelatedWork W1985566068 @default.
• W1981975662 hasRelatedWork W1985650770 @default.
• W1981975662 hasRelatedWork W2001415515 @default.
• W1981975662 hasRelatedWork W2004885591 @default.
• W1981975662 hasRelatedWork W2012919149 @default.
• W1981975662 hasRelatedWork W2037578345 @default.
• W1981975662 hasRelatedWork W2076046493 @default.
• W1981975662 hasRelatedWork W2089486656 @default.
• W1981975662 hasRelatedWork W2316616308 @default.
• W1981975662 hasRelatedWork W2321536032 @default.
• W1981975662 hasRelatedWork W2325951532 @default.
• W1981975662 hasRelatedWork W2335490777 @default.
• W1981975662 hasRelatedWork W2498172189 @default.
• W1981975662 hasRelatedWork W2500446133 @default.
• W1981975662 hasRelatedWork W2911654206 @default.
• W1981975662 hasRelatedWork W2942493487 @default.
• W1981975662 hasRelatedWork W2953064945 @default.
• W1981975662 hasRelatedWork W3083003723 @default.
• W1981975662 hasRelatedWork W3085032699 @default.
• W1981975662 hasRelatedWork W3175712893 @default.
• W1981975662 isParatext "false" @default.
• W1981975662 isRetracted "false" @default.
• W1981975662 magId "1981975662" @default.
• W1981975662 workType "article" @default.